Haining Health-Coming Biotech Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Haining Health-Coming Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Trial of Docetaxel With or Without XH1 in Non-small Cell Lung Cancer (NSCLC) Patients (NCT03407300) | Haining Health-Coming Biotech Co., Ltd. | 2018-02-01 |
Track Haining Health-Coming Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.